BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 7682535)

  • 1. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
    Vandenberghe P; Ceuppens JL
    Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
    Lu Y; Granelli-Piperno A; Bjorndahl JM; Phillips CA; Trevillyan JM
    J Immunol; 1992 Jul; 149(1):24-9. PubMed ID: 1318900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell activation via Leu-23 (CD69).
    Testi R; Phillips JH; Lanier LL
    J Immunol; 1989 Aug; 143(4):1123-8. PubMed ID: 2501389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA
    Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
    Borrego F; Peña J; Solana R
    Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation.
    Ledbetter JA; Rabinovitch PS; Hellström I; Hellström KE; Grosmaire LS; June CH
    Eur J Immunol; 1988 Oct; 18(10):1601-8. PubMed ID: 2461308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
    Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
    J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of resting human gamma delta T lymphocytes by interleukin-2.
    Kjeldsen-Kragh J; Quayle AJ; Skålhegg BS; Sioud M; Førre O
    Eur J Immunol; 1993 Sep; 23(9):2092-9. PubMed ID: 8370391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.
    Baroja ML; Ceuppens JL; Van Damme J; Billiau A
    J Immunol; 1988 Sep; 141(5):1502-7. PubMed ID: 3261751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH; Ledbetter JA; Lindsten T; Thompson CB
    J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
    de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
    Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.